Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
labetalol alpha-1 adrenergic receptors small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Systemic arterial pressure[MeSHID:D062186]
Blood Pressure[MeSHID:D001794]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.41 approved antagonist
labetalol alpha-1 adrenergic receptors small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Systemic arterial pressure[MeSHID:D062186]
Blood Pressure[MeSHID:D001794]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.13 approved antagonist
labetalol alpha-1 adrenergic receptors small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Systemic arterial pressure[MeSHID:D062186]
Blood Pressure[MeSHID:D001794]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.1 approved antagonist
labetalol beta-1 adrenergic receptor small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Systemic arterial pressure[MeSHID:D062186]
Blood Pressure[MeSHID:D001794]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.59 approved antagonist
labetalol beta-2 adrenergic receptor small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Systemic arterial pressure[MeSHID:D062186]
Blood Pressure[MeSHID:D001794]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.35 approved antagonist
click here to return to the previous page